Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

This Says Our Favorite Biotech Is Off to the Races

Shares of Inovio Pharmaceuticals Inc. (NYSE: INO) – a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Inovio’s shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. Inovio shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

  • Featured Story

    How the Apple (Nasdaq: AAPL) iPhone Will Save Millions of Lives-and Make Early Investors a Bundle

    It's hard to believe, but it's true. The iPhone turns five years old next week.

    Since its official launch on June 29, 2007, Apple Inc. (Nasdaq: AAPL) has sold well over 180 million iPhones. Hands down, it's the most successful mobile phone ever launched.

    But what most investors don't realize is the huge impact the iPhone has had on medicine.

    The fact is, more than any other product on the planet, the iPhone is driving a whole new sector called mobile healthcare, or mHealth for short.

    With an iPhone in hand, it will redefine how doctors and other health-care pros work with their patients.

    But here's the big payoff: mHealth promises to save millions of lives as doctors use it to detect and treat diseases much more quickly than they could with old-school devices.

    These radical advances will undoubtedly make lots of early mHealth investors quite rich.

    But don't take my word for it....

    A trade group known as GSMA says the mobile healthcare sector will reach total sales of $23 billion by 2017.

    Of course, phones and tablets that use Google Inc.'s (Nasdaq: GOOG) Android operating system also could play a big role in the sector.

    But at this point the iPhone remains the clear leader in this rapidly growing market.

    It's So Much More Than a Phone

    That's why I'm glad to introduce you to a startup firm that has staked much of its future on the iPhone platform.

    To continue reading, please click here...

    Read More...
  • iOS6

  • WWDC 2012: Apple (Nasdaq: AAPL) Unveils MacBooks, iOS 6 While the new laptops Apple Inc. (Nasdaq: AAPL) unveiled at WWDC 2012 may draw the most attention, it's the upgrades to its two operating systems that in the long run will mean more to the company's bottom line.

    The Worldwide Developers Conference is Apple's annual event aimed at those who write apps for Macs, iPhones and iPads.

    WWDC's "grabber" product is the next generation MacBook Pro. This very thin laptop -- 0.71 inches - features the same high-resolution Retina display technology as the iPhone 4s and the third-generation iPad. It adds ports using the new USB 3.0 standard as well as Intel Corp.'s (Nasdaq: INTC) developed Thunderbolt technology.

    Of course, all the fancy new bells and whistles come at a price - this fancy new MacBook Pro starts at $2,199.

    Apple also unveiled upgrades to the rest of its MacBook line, which were all blessed with Intel's new "Ivy Bridge" chipset in addition to USB 3.0.

    The popular MacBook Air also got something unexpected: a $100 price cut on both base models. That puts Apple's cheapest laptop at $999, a clear attempt to better compete with "ultrabooks" - the MacBook Air's Windows PC imitators.

    Contrary to rumors, a new Mac Pro desktop did not appear at WWDC 2012. Perhaps the changes are major enough to warrant a separate "Apple event" later in the year.

    To continue reading, please click here...
    Read More...